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In many bacteria and archaea, an adaptive immune system (CRISPR–Cas) provides immunity against
foreign genetic elements. This system uses CRISPR RNAs (crRNAs) derived from the CRISPR array,
along with CRISPR-associated (Cas) proteins, to target foreign nucleic acids. In most CRISPR systems,
endonucleolytic processing of crRNA precursors (pre-crRNAs) is essential for the pathway. Here we
study the Cas6 endonuclease responsible for crRNA processing in the Type III-A CRISPR–Cas system
from Staphylococcus epidermidis RP62a, a model for Type III-A CRISPR–Cas systems, and define sub-
strate requirements for SeCas6 activity. We find that SeCas6 is necessary and sufficient for full-
length crRNA biogenesis in vitro, and that it relies on both sequence and stem-loop structure in
the 30 half of the CRISPR repeat for recognition and processing.
 2015 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
All genomes are susceptible to attack by foreign DNA, necessi-
tating mechanisms of protection against invasion. Most bacteria
and archaea encode various innate defense systems, but because
of ongoing phage evasion of host defense systems, cells benefit
from access to a more sophisticated, adaptive immune system. In
recent years, CRISPR (clustered regularly interspaced, short palin-
dromic repeat) systems have been shown to specify an adaptive
immune system that is present in most archaea and 40% of bac-
teria [1–4]. CRISPR loci are made up of identical repeat sequences
interspaced by unique spacer sequences that are derived frominvasive genomes. Multiple protein-coding genes called cas
(CRISPR-associated) genes can usually be found adjacent to the
CRISPR locus. CRISPR systems are divided into five major types
(I–V) and further classified into 16 subtypes (I-A through I-F and
I-U, II-A through II-C, III-A through III-D, as well as IV and V) based
upon CRISPR locus architecture, cas gene repertoire and interfer-
ence mechanism [5]. These classifications reflect the diversity with
which CRISPR pathways confer immunity [1,3–5].
The proteins encoded by the cas genes, together with small
RNAs that are encoded by the CRISPR array, mediate CRISPR immu-
nity in three main stages: adaptation, crRNA biogenesis, and tar-
geting [1,3,4]. During the adaptation stage, a bacterial or archaeal
host acquires resistance against an invasive element by integrating
a ‘‘protospacer” fragment of that element into its CRISPR locus [6],
thereby forming a new spacer that confers sequence-based immu-
nity against subsequent invasion by the same element [7]. CrRNA
biogenesis involves the transcription of the CRISPR locus to gener-
ate a crRNA precursor (pre-crRNA) that is then processed into
mature crRNAs [8,9], each of which harbors a single spacer flanked
by partial repeat sequences [8–11]. In most Type I and Type III
CRISPR–Cas systems, crRNA biogenesis depends on a member of
the Cas6 protein family, which recognizes and cleaves the pre-
crRNA within the repeat elements [11]. In the targeting stage of
CRISPR interference, cRNAs are used as guide sequences that form
ribonucleoprotein effector complexes with one or more Cas pro-
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acids (usually within invasive sequences) by Watson–Crick base
pairing. A Cas protein within the complex then cleaves the identi-
fied target, driving the sequence-specific targeting of invaders.
The Type III-A machinery is emerging as a particularly versatile
CRISPR–Cas system. The prototypical Type III-A CRISPR–Cas system
(from Staphylococcus epidermidis RP62a) was the first to have its
target defined as DNA rather than RNA, [12], and that activity
has been shown recently to depend upon transcription across the
targeted locus [13,14]. Recent biochemical analyses have also
revealed an RNA-cleaving activity [14] that is shared by other Type
III-A systems [15,16]. Both activities depend strictly on a processed
crRNA guide. Further study of the S. epidermidis Type III-A system’s
mechanistic features, from crRNA biogenesis, Csm complex assem-
bly, and RNA/DNA target cleavage, will be important for under-
standing the basis for its unusual versatility.
Here we study crRNA biogenesis in the S. epidermidis RP62a
Type III-A pathway. In this system, crRNA biogenesis occurs in
two stages. During primary processing, S. epidermidis Cas6 (SeCas6)
cleaves the pre-crRNA to generate a 71-nt intermediate crRNA
[17,18]. SeCas6 is an endoribonuclease belonging to the ‘‘repeat-
associated mysterious protein” (RAMP) family [19], members of
which adopt a unique ferridoxin-like fold. Genetic analyses indi-
cate that no other S. epidermidis Cas proteins are required for this
step in vivo [17,18,20]. Following primary processing, one or more
nucleases trims the intermediate’s 30 end in 6-nucleotide (nt)
increments to generate mature crRNAs that range in size from 31
to 67 nt [17,18]. Within cells, mature crRNA accumulation requires
the Cas proteins Csm2, Csm3 and Csm5 [17], which form the Csm
ribonucleoprotein complex along with Csm4, Cas10 and crRNA
[14,18,20]. SeCas6 appears to function independently during pro-
cessing, and not as a stable component of its cognate effector com-
plex [14,18,20], unlike the Cas6 orthologs from most Type I
systems [8,21]. Although these aspects of crRNA maturation have
been examined in cells [17,20], the biochemical basis for S. epider-
midis crRNA processing [18], in preparation for Csm effector com-
plex loading, is less well understood. Here we define the pre-crRNA
repeat features that are necessary for SeCas6 recognition and pri-
mary processing.2. Materials and methods
2.1. Plasmid construction, growth conditions and cell extract
preparation
For pre-crRNA processing assays using cell extracts, we used
S. epidermidis strains RP62a, LAM104 (an RP62a derivative carrying
a precise deletion of the CRISPR repeats and spacers) [12], or strain
LM1680 and its derivatives harboring the pcrispr plasmid (all gen-
erously provided by Luciano Marraffini, Rockefeller University,
New York, NY) [18]. LM1680 and its derivatives are described in
Table 1 of Hatoum-Aslan et al. [18]. Cell extract was prepared by
growing 0.5 liters of S. epidermidis cells in Brain Heart Infusion
media (BHI; Difco) at 37 C until the culture reached an
OD600  2. The mediumwas supplemented with antibiotics as fol-
lows: neomycin (15 lg/ml) for selection of S. epidermidis LM1680
and chloramphenicol (10 lg/ml) for selection of pcrispr. Cells were
harvested via centrifugation and washed successively with 50 ml
of cold S30 buffer A [10 mM Tris–acetate (pH 8.0), 14 mM magne-
sium acetate, 1 mM KCl, and 1 mM DTT] and then 25 ml of buffer A
[10 mM Tris–acetate (pH 8.0), 14 mM magnesium acetate, 50 mM
KCl, and 1 mM DTT]. Cells were re-suspended to a final volume
of 8.25 ml in buffer B [10 mM Tris–acetate (pH 8.0), 20 mMmagne-
sium acetate, 50 mMKCl, and 1 mMDTT] and were lysed by adding
0.1 mg lysostaphin (Sigma–Aldrich) followed by incubation at37 C for 60 min. Cellular debris was removed via centrifugation
in an SS34 rotor (Sorvall) at 30,000g for 15 min. 0.25 volumes
of pre-incubation buffer [670 mM Tris–acetate (pH 8.0), 20 mM
magnesium acetate, and 7 mM DTT] was added to the supernatant
and incubated at 37 C for 30 min. The preincubated supernatant
was collected and the buffer was exchanged to storage buffer
[10 mM Tris–acetate (pH 8.0), 14 mM magnesium acetate, 60 mM
potassium acetate, 1 mM DTT, 5% glycerol], and split into 100 ll
aliquots, flash-frozen in liquid nitrogen, and stored at 80 C.
2.2. Preparation of RNA substrates
For preparation of RNA substrates containing repeat 1, spacer 1,
repeat 2, and truncated spacer 2 (see Fig. 1A and B), we generated a
DNA template by PCR amplification from S. epidermidis RP62a
CRISPR sequences using a forward primer containing a T7 pro-
moter (50-TAATACGACTCACTATAGGGACAGCAAAAATGATGCTTG-30)
and a reverse primer corresponding to a portion of the second
spacer (50-GTAACGTATGCAAATGACAATTA-30). The amplified DNA
was gel-purified, cloned into the pCR2.1 TOPO vector (Life Tech-
nologies), and confirmed by DNA sequencing. The RNA substrate
generated by EcoRI digestion and T7 RNA polymerase transcription
includes two 50-terminal G residues (to facilitate in vitro transcrip-
tion) followed by: 53 nts of CRISPR leader sequence; the 36-nt
CRISPR repeat 1; the 35-nt spacer 1; the 36-nt repeat 2; 29 nts of
spacer 2; and 11 nts of plasmid-derived sequence (203 nts total).
Substrate mutants were generated using the QuikChange Site-
Directed Mutagenesis Kit (Agilent) and confirmed by DNA
sequencing. RNAs were generated by in vitro transcription using
T7 RNA Polymerase (New England Biolabs) and uniformly labeled
with 20 lCi [a-32P] CTP (3000 Ci/mmol; Perkin-Elmer), 500 lM
ATP, 500 lM GTP and 500 lM UTP, 12 lM unlabeled CTP (New
England Biolabs), 1 RNA polymerase buffer (New England Bio-
labs), and 20 U T7 RNA polymerase in a total volume of 20 ll.
The RNAs were separated by electrophoresis in a denaturing (8 M
urea) 10% polyacrylamide gel, and the appropriate RNA species
were excised from the gel with a sterile razor blade after autora-
diographic exposure. The RNA was eluted from the gel slices by
end-over-end rotation in 400 ll of RNA elution buffer [0.3 M
sodium acetate, 0.5 mM ethylenediaminetetraacetic acid (EDTA),
0.5% SDS, 5 mM Tris (pH 7.5)] for 6 h at room temperature. The
RNA was precipitated with 2.5 volumes of 100% ethanol after incu-
bation for 2 h at 20 C. For RNA substrates consisting of repeat
sequences only (and repeat truncations), we annealed 100 lm for-
ward and reverse synthetic DNA oligos (IDT) harboring a T7 pro-
moter, and cloned them into a modified pUC57 vector. The
vector was linearized with BbsI restriction enzyme and RNAs were
generated using the MEGAscript T7 transcription kit (Life technolo-
gies). RNAs were run on an 8 M urea, 12% polyacrylamide gel and
excised from the gel following UV shadowing by a 254 nm lamp.
RNA was eluted from the gel slice and precipitated as described
above. These RNAs were 50 end-labeled with T4 polynucleotide
kinase (New England Biolabs) in a 20 ll reaction containing
20 pmol RNA, 500 lCi of [c32P] ATP (7000 Ci/mmol; MP Biomedi-
cal) and 20 U of T4 polynucleotide kinase. Labeled RNAs were sep-
arated on an 8 M urea, 12% polyacrylamide gel and purified
according to the protocol outlined above.
2.3. Expression and purification of recombinant SeCas6
Cultures of Escherichia coli Rosetta (DE3) cells (EMD Millipore)
containing a pET21a vector encoding an N-terminally His6-
tagged SeCas6 (gift from Alfonso Mondragón) were grown at
37 C in Terrific Broth (TB) containing 100 lg/ml of ampicillin
and 34 lg/ml chloramphenicol until the culture reached an OD600
of 0.8. Recombinant His6-SeCas6 expression was induced by
Fig. 1. Cas6 is responsible for primary processing of pre-crRNA transcripts in S. epidermidis. (A) Organization of the S. epidermidis RP62a CRISPR locus. Leader (black box),
repeats (grey diamonds), spacers (colored rectangles), and cas/csm genes (grey arrows) are indicated. Individual elements are not to scale. The 36-nt sequence of each CRISPR
repeat is given above, with the proposed stem-loop and the cleavage site (between nts 28 and 29) indicated. (B) Schematic representation of a model pre-crRNA substrate, and
its primary processing in vitro. Using in vitro transcription, we generated a body-labeled, truncated pre-crRNA that includes two spacers [red (Spc1) and blue (Spc2)] and two
repeats (grey). The transcribed pre-crRNA is subject to primary processing events, one within each repeat (sites indicated by a dotted line), that liberate an intermediate
crRNA (71 nt) or two crRNA fragments (84 and 48 nt), as indicated. (C) In vitro crRNA processing using extracts from wildtype, Dcrispr/cas, Dcrispr, and individual Dcas/csm
gene in-frame deletion strains. The reaction products [see the schematic in (B)] are indicated to the right. M: DNA size markers (sizes indicated on the left); Input:
unprocessed substrate.
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16 C with constant shaking. Cells were harvested via centrifuga-
tion and all subsequent protein purification steps were performed
at 4 C.
For purification of His6-SeCas6, cells were resuspended in 20 ml
of Buffer A [50 mM Tris–HCl (pH 8.0), 500 mM NaCl, 5 mM imida-
zole (pH 8.0), 5% glycerol] containing 0.75 mM phenylmethylsul-
fonyl fluoride (PMSF), 1 mM Benzamidine, and 1 lg/ml Pepstatin.
Harvested cells were disrupted by sonication. Insoluble material
was cleared by centrifugation for 35 min at 38,000 rpm in a Beck-
man Coulter centrifuge using a Ti-60 rotor. The resulting super-
natant was passed through a 0.2 lm filter and loaded onto a
Talon metal affinity Co2+ resin (Takara) column equilibrated with
Buffer A. The column was washed with 300 ml of buffer A and
the protein was subsequently eluted step-wise with 100 ml of Elu-
tion buffer [50 mM Tris–HCl (pH 8.0), 500 mM NaCl, 5% glycerol)
containing 50, 100, and 500 mM imidazole, and collected in
10 ml aliqouts. His6-SeCas6 was analyzed using SDS–PAGE and
staining with Coomassie Blue. The 100 mM imidazole eluates con-
taining purified His6-SeCas6 were pooled and the buffer was
exchanged to storage buffer [50 mM Tris–HCl (pH 8.0), 500 mM
NaCl, 250 mM imidazole (pH 8.0), 5% glycerol) using Spectra/Por
molecular porous membrane tubing (Spectrum Labs).
2.4. RNA cleavage reactions
Recombinant SeCas6 protein (rSeCas6; 500 nM) was incubated
with trace amounts of end-labeled or body-labeled RNA in nucle-
ase assay buffer [880 mM potassium acetate, 20 mM Tris acetate
(pH 8.0), 2 mM EDTA] and dialysis buffer [10 mM Tris acetate
(pH 8.0), 150 mM potassium acetate, 1 mM DTT, 5% glycerol] at
37 C for 5 min in a 20 ll reaction. 10 ll samples were removedfrom the reaction and quenched in 10 ll of quenching buffer
(1 lg/ll of Proteinase K and 1% SDS) and incubated at 37 C for
15 min. RNAs were recovered by phenol/chloroform extraction
and ethanol precipitation and then separated by electrophoresis
in a denaturing (8 M urea), 10–12% polyacrylamide gel. The gels
were dried and radiolabeled RNAs were visualized by
phosphorimaging.
3. Results
3.1. SeCas6 is necessary and sufficient for crRNA primary processing in
S. epidermidis
S. epidermidis RP62a harbors a Type III-A CRISPR-cas locus that
contains nine cas/csm genes, as well as four CRISPR repeats and
three spacers (spc1, spc2 and spc3) (Fig. 1A) [12]. CrRNAs generated
from spc1 direct interference against conjugation by targeting the
nickase (nes) gene that is carried on conjugative plasmids
[12,17,18,20,22]. Pre-crRNA processing is essential for this and
other forms of CRISPR interference in this system [17,18,20], and
depends upon cas6 [17,18,20]. Primary processing by Cas6 occurs
between nts 28 and 29 of the crRNA repeat, immediately following
a proposed four-bp stem (Fig. 1A). To investigate further the roles
of the Cas/Csm machinery in pre-crRNA processing, we used an
in vitro system that tracks site-specific cleavage of a body-
labeled S. epidermidis pre-crRNA substrate, encompassing 55
50-flanking nts, repeat 1, spacer 1, repeat 2, and most of spacer 2
(Fig. 1B, top). When this model pre-crRNA substrate is fully
cleaved, three products are expected: an 84-nt 50-terminal bypro-
duct that includes nts 1–28 of repeat 1 along with its upstream
flank; the spc1 intermediate crRNA (71 nts); and a truncated spc2
crRNA (48 nts) (Fig. 1B, bottom). We prepared crude extracts from
3200 N. Wakefield et al. / FEBS Letters 589 (2015) 3197–3204S. epidermidis cells, incubated them with radiolabelled model pre-
crRNA substrate, and then analyzed the resulting RNAs by denatur-
ing gel electrophoresis and autoradiography (Fig. 1C). For extract
preparation we used the RP62a-derivedmutant strain LM1680 that
harbors a large deletion that removes the entire crispr/cas locus
(Dcrispr/cas) [18]. We also used LM1680 complemented with a
plasmid that includes the entire CRISPR-cas locus (pcrispr), or with
pcrispr derivatives that remove the CRISPR repeats and spacers
(Dcrispr) or that carry in-frame deletions of each individual cas/
csm gene that is essential for plasmid interference (Dcas10, Dcsm2,
Dcsm3, Dcsm4, Dcsm5, Dcsm6, or Dcas6) [17,18,20]. We observed
the intact 71-nt intermediate crRNA (as well as the 84-nt 50-
terminal byproduct) in all pcrispr complementation strains except
for the Dcas6 derivative. The limited accumulation of the other
partially processed products likely reflects poor stability of those
RNAs in the crude extract. These results provide biochemical con-
firmation that cas6, alone among the cas/csm genes, is required for
primary pre-crRNA processing in S. epidermidis RP62a [17].
To test whether SeCas6 is sufficient for primary pre-crRNA pro-
cessing in this Type III-A system, we expressed recombinant
SeCas6 (rSeCas6) protein in E. coli and purified it to homogeneity
(Fig. S1). Incubation of the model pre-crRNA substrate (Fig. 1B)
with rSeCas6 led to the rapid, efficient appearance of processing
products and byproducts (Fig. 2). All products and byproducts were
readily detectable, consistent with a lack of non-specific RNA
degradation in this purified system. For comparison, we concur-
rently tested processing efficiency in crude cellular extract [in this
case from the RP62a-derived strain LAM104, which lacks the
CRISPR locus (and therefore lacks endogenous crRNAs) but
includes all chromosomal cas/csm genes] [12]. We used this
CRISPR-deleted strain to avoid potential competitive effects (if
any) from endogenous pre-crRNAs. Although cellular extract wasFig. 2. Purified, recombinant SeCas6 reconstitutes pre-crRNA processing in vitro.
The model pre-crRNA depicted in Fig. 1B was uniformly labeled and incubated for
2.5 and 5 min in the presence (+) or absence () of 500 nM rSeCas6 protein, as
indicated at the top of each lane. For comparison, processing reactions were also
done in crude extract from S. epidermidis cells (strain LAM104) that express native
SeCas6. The reaction products (see the schematic in Fig. 1B) are indicated to the
right. M: DNA size markers (sizes indicated on the left); Input: unprocessed
substrate.again successful at generating the 71-nt intermediate crRNA, accu-
mulation was more modest, and most other reaction products
were absent, consistent with RNA degradation (Fig. 2). Our results
confirm that SeCas6 is sufficient for pre-crRNA processing in the S.
epidermidis CRISPR-Cas system [20]. Because rSeCas6 processing is
more efficient than crude extract and is also less prone to non-
specific RNA degradation, we used this purified system for our sub-
sequent experiments.
3.2. In vitro pre-crRNA processing by rSeCas6 requires specific
sequence elements within the CRISPR repeat
Mutagenic analyses in S. epidermidis cells have identified CRISPR
repeat nts that are important for processed crRNA accumulation
and interference, and identified the three nts on either side of
the SeCas6 cleavage site (between G28 and A29; Fig. 1A) as being
particularly crucial [17]. To test whether these nts function during
the pre-crRNA processing itself (rather than, for example, post-
processing RNA stability), we mutagenized the first repeat in the
pre-crRNA that we had previously developed for in vitro process-
ing. Initially we mutated four contiguous nts at a time (changing
each nt to its Watson–Crick complementary nt) to identify
sequence blocks that include potential SeCas6 recognition ele-
ments. All mutations were introduced into Repeat 1, whereas the
wild-type Repeat 2 sequence was retained in all cases. Accordingly,
cleavage within Repeat 2 served as an internal positive control for
SeCas6 activity. A series of mutated pre-crRNAs was used in
in vitro processing reactions with purified rSeCas6.
The results of this analysis are shown in Fig. 3. Two block sub-
stitutions – within nts 25–28 (the four G residues on the 30 side of
the predicted stem, immediately upstream of the cleavage site;
Fig. 3A) and nts 29–32 (immediately downstream of the cleavage
site) – resulted in strong processing defects (Fig. 3B). These defects
were reflected in the loss of the 71-nt intermediate crRNA, and in
the accumulation of the partially processed substrate (including 50
flank, Repeat 1, Spacer 1, and most of Repeat 2) that had been
cleaved within Repeat 2 only. These tetranucleotide substitutions
include the nts that were previously shown to be important for
crRNA accumulation in cells [17]. Mutation of repeat nts 13–16
(the four C residues on the 50 side of the proposed stem) also
yielded a partial defect, with diminished intermediate crRNA accu-
mulation and moderately increased partially-processed substrate
(Fig. 3C). Although none of the nts from positions 13–16 were
required individually for crRNA accumulation in cells [17], the
quadruple mutation would be expected to abolish stem formation,
and the in vivo mutagenesic analyses did provide some support for
a requirement for base pairing within the stem [17]. All other four-
nt substitutions (beyond those in nts 13–16, 25–28, and 29–32)
had little or no effect on pre-crRNA processing (Fig. 3B and C).
For the 13–16 and 25–28 substitutions, all mutations were
upstream of the Repeat 1 cleavage site, and the resulting 71-nt
intermediate crRNA therefore had a fully wildtype RNA sequence.
Accordingly, the diminished or abolished 71-nt crRNA accumula-
tion in those mutants (Fig. 3B and C) is likely to be caused solely
by a primary processing defect rather than from increased suscep-
tibility to post-processing RNA degradation.
To deconvolute the effects of the four mutations within each
mutagenically sensitive block (repeat nts 13–16, 25–28, and 29–
32), we constructed the corresponding single mutations and tested
them in the rSeCas6 processing assay (Fig. 4A). Only four nts – C30
(two nts downstream of the cleavage site) (Fig. 4B) and G26, G27,
and G28 (the three nts upstream of the cleavage site) (Fig. 4C) –
yielded strong processing defects that abolished crRNA generation.
Mutation of several other nts [A29, immediately downstream of
the cleavage site (Fig. 4B); G25, at the top of the 3’ side of the pro-
posed stem (Fig. 4C); and C13, C14, C15, and C16, on the 50 side of
Fig. 3. In vitro processing analysis of pre-crRNA carrying block mutations within
the first CRISPR repeat. (A) The sequence of Repeat 1, with the predicted hairpin-
forming nucleotides underlined. Nt numbering is shown. (B and C) rSeCas6-
catalyzed pre-crRNA cleavage reactions with a series of pre-crRNAs carrying
quadruple mutations (with the indicated repeat nts replaced by their respective
Watson–Crick complementary nts). In each case the mutations were in repeat 1
only, while the wildtype sequence of repeat 2 was retained to provide an internal
positive control for rSeCas6 processing activity. Cleavage assays were performed
using uniformly radiolabeled RNAs in the presence (+) or absence () of rSeCas6.
The reaction products (see the schematic in Fig. 1B) are indicated to the right. In:
input (unprocessed substrate); M: DNA size markers (sizes indicated on the left).
Nts that exhibit a substantial processing defect when mutated are highlighted in
red above each panel, and in the sequence at the top of the figure.
Fig. 4. In vitro processing analysis of pre-crRNA carrying single-nt mutations
within the first CRISPR repeat. (A) The sequence of Repeat 1, with the predicted
hairpin-forming nucleotides underlined. Nt numbering is shown. (B and C) rSeCas6-
catalyzed pre-crRNA cleavage reactions with a series of pre-crRNAs carrying single
mutations (with each indicated repeat nt replaced by its Watson–Crick comple-
mentary nt). In each case the mutation was in repeat 1 only, while the wildtype
sequence of repeat 2 was retained to provide an internal positive control for
rSeCas6 processing activity. Cleavage assays were performed using uniformly
radiolabeled RNAs in the presence (+) or absence () of rSeCas6. The reaction
products (see the schematic in Fig. 1B) are indicated to the right. In: input
(unprocessed substrate); M: DNA size markers (sizes indicated on the left).
Individual nts that exhibit a substantial processing defect when mutated are
highlighted in red above each panel, and in the sequence at the top of the figure.
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crRNA generation, but nonetheless induced some accumulation of
partially processed substrate cleaved within Repeat 2 only. This
suggests partial processing defects in those mutants. Furthermore,
our observation that the wild-type Repeat 2 is efficiently cleaved in
all of the Repeat 1 mutant substrates (Figs. 3 and 4) confirms that
rSeCas6 pre-crRNA processing is unit-independent, i.e. involves no
discernable interaction or cooperativity from one pre-crRNA repeat
processing unit to another. This conclusion is also consistent with
previous in vivo results [17].
To corroborate the results of the substitution mutations, and to
define the regions of the pre-crRNA repeat that are completely dis-
pensable for processing, we tested the ability of rSeCas6 to cleave
short RNAs consisting of a single repeat only, or truncation deriva-
tives thereof (Fig. 5A). Truncation of the 50 end of the repeat (the 50-
terminal 4, 5, 8, 10, or 12 nts) or the 30 end of the repeat (the 30-
terminal 2, 5, or 6 nts) all retained the important nts identified
above, and were all cleaved by rSeCas6 (Fig. 5B). Simultaneous
truncation from both ends (substrate 12–31, Fig. 5A), consisting
of the stem-loop and only one additional nt upstream and two
additional nts downstream, was also accurately cleaved, indicating
that the stem-loop and the 1–2 nts that immediately flank itinclude all sequences that are necessary for rSeCas6 recognition
and cleavage.
3.3. The role of the repeat stem-loop structure in SeCas6 pre-crRNA
processing
The processing defects observed in mutants involving C13, C14,
C15, and C16 (the nts on the 50 side of the proposed stem; Fig. 6A),
or in mutants involving G25, G26, G27, or G28 (the nts on the 30
side of the proposed stem), could result from the loss of base-
specific SeCas6-RNA contacts, or from the loss of secondary struc-
tural elements that are important for SeCas6 recognition, or both.
To distinguish between these alternatives, we tested whether com-
pensatory mutations in the stem could reverse the defects of
Fig. 5. An individual CRISPR repeat RNA, and truncation derivatives thereof, are accurately cleaved by rSeCas6 in vitro. (A) Sequences of the wild-type and mutant repeat
RNAs. In some cases, one or two G residues (bold, and not included in the numbering scheme) were added to the 5’ end to facilitate in vitro transcription. (B) Detailed analysis
of cleavage with a series of crRNAs and mutant derivatives. Cleavage assays were performed using 50-end-radiolabeled RNAs in the presence (+) or absence () of purified
rSeCas6.
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G27C, and G28C mutants because they exhibited the strongest
defects in rSeCas6 cleavage (Fig. 4C). In all three cases, the compen-
satory double mutant (C15G/G26C, C14G/G27C, and C13G/G28C)
failed to revert the processing defect observed in the G? C muta-
tion alone (Fig. 6A). This suggests that base pairing interactions at
those positions are not sufficient for rSeCas6 processing. The lim-
ited processing defect of the G25C mutant (Fig. 4C) could be par-
tially overcome in the compensatory double mutant (C16G/
G25C), indicating that base pairing at this position (or its contribu-
tion to overall stem stability) plays a role in SeCas6 processing.
In all of the substitution mutants described above, the wildtype
nt was changed to its Watson–Crick complement, meaning that all
mutations were purine? pyrimidine or pyrimidine? purine
transversions. It remained possible that purine? purine or pyrim-
idine? pyrimidine transition mutations that nonetheless main-
tain base pairing could support SeCas6 processing, even in cases
where transversion mutations could not. To address this, we con-
structed compensatory double mutants involving C? T and G?
A transition mutations (C15T/G26A, C14T/G27A, and C13T/G28A),
in the context of a single-repeat processing substrate. We also con-
structed an octanucleotide substitution substrate in which all four
C residues (C13-16) were changed to T residies, and all four G resi-
dues (G25-28) were changed to A residues. No processing was
observed for the octanucleotide substitution (Fig. 6B), indicating
that the potential for stem formation (while retaining purine and
pyrimidine identity at each position) does not suffice for SeCas6
recognition and processing. For the less drastic mutations, two of
the individually mutated base pairs that had failed to tolerate com-
pensatory transversion mutations (C13G/G28C and C14G/G27C;
Fig. 6A) likewise failed to tolerate compensatory transition muta-
tions (C13T/G28A and C14T/G27A; Fig. 6B). In contrast, the third
base pair that had failed to tolerate a compensatory transversion
mutation (C15G/G26C; Fig. 6A) could be cleaved when compen-
satory transition mutations were used instead (C15T/G26A;Fig. 6B). Taken together, our compensatory analyses provide some
support for a role for pairing in the top two base pairs of the pro-
posed stem (C15/G26 and C16/G25). For the bottom two base pairs
(C13/G28 and C14/G27), the strong (G27C and G28C) andmoderate
(C13G and C14G) defects observed in individual mutants does not
rule out a partial role for base pairing at these positions. Nonethe-
less, the failure of all of these sites’ compensatory mutations (both
transitions and transversions) to restore processing indicates that
base pairing is certainly not sufficient, and suggests that SeCas6
requires base-specific recognition elements at these sites. Accord-
ingly, SeCas6 appears to use a combination of sequence- and
structure-specific recognition to identify its processing substrates.
4. Discussion
Universal to all CRISPR systems described thus far is the tran-
scription of repeat-spacer units into long precursors that are
cleaved endonucleolytically within each repeat sequence. With
few exceptions [23], the generation of mature crRNA is a critical
step in CRISPR immunity [8,11]. These short crRNAs, each harbor-
ing a unique invader-derived spacer sequence, can help assemble
Cas protein-containing effector complexes, and guide these com-
plexes to recognize and destroy invader sequences. In Type I and
Type III systems, primary pre-crRNA processing occurs by way of
the Cas6 family of nucleases [8,9], with the exception of Type I-C
systems, in which Cas5d fulfills this role [24,25]. Although Cas6
sequences are highly divergent, they share the ability to adopt sin-
gle or double ferridoxin-like ‘‘RNA Recognition Motif” (RRM) folds
that employ metal-independent mechanisms to cleave their sub-
strates [26–28].
In S. epidermidis, pre-crRNA maturation occurs in two distinct
steps, first liberating an intermediate crRNA that is flanked by
repeat sequence on either end, followed by 3’ trimming in the sec-
ond ‘‘maturation” stage of biogenesis [17,18]. Neither intermediate
nor mature crRNAs accumulate in the absence of Cas6, Cas10, or
Fig. 6. Compensatory mutational analyses of CRISPR repeat stem-loop base pairs.
(A) rSeCas6-catalyzed pre-crRNA cleavage reactions with pre-crRNAs carrying
single G? C mutations on the 30 side of the stem (as in Fig. 4C), but also carrying
the compensatory C? G mutation on the 50 side of the stem. Repeat 1, with the
predicted hairpin structure, is depicted above. Stem nt numbering and the site of
SeCas6 cleavage are indicated. In each case the mutations were in repeat 1 only,
while the wildtype sequence of repeat 2 was retained to provide an internal
positive control for rSeCas6 processing activity. Cleavage assays were performed
using uniformly radiolabeled RNAs in the presence (+) or absence () of rSeCas6.
The reaction products (see the schematic in Fig. 1B) are indicated to the right. In:
input (unprocessed substrate); M: DNA size markers (sizes indicated on the left).
Substrates that exhibit a substantial processing defect when mutated are high-
lighted in red above the panel. (B) rSeCas6-catalyzed repeat cleavage assays (similar
to those in Fig. 5) with substrates carrying compensatory transition rather than
transversion mutations in the proposed stem. Cleavage assays were performed
using internally radiolabeled RNAs in the presence (+) or absence () of rSeCas6. In:
input (unprocessed substrate). In this experiment, the wildtype substrate is
identical to that depicted in the top row of Fig. 5A, except that it has one fewer
nt on each end. The mutant RNAs are as shown on the top row of Fig. 5A, except for
the specified base substitutions indicated at the top of each lane. Substrates that
exhibit a substantial processing defect when mutated are highlighted in red above
the panel.
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the absence of Csm2, Csm3, and Csm5 [17]. The relative roles of the
different S. epidermidis Cas/Csm proteins in primary processing
itself, rather than in post-processing stabilization of the intermedi-
ate crRNA, are only partially understood [18]. Here we have used a
biochemical approach to characterize further the biogenesis of
intermediate crRNAs in this system. As with most Type III
CRISPR–Cas systems, we confirm that SeCas6 is both necessary
and sufficient for the processing of S. epidermidis pre-crRNAs
(Figs. 1 and 2) [20]. This observation indicates that the roles ofCas10 and Csm4 in crRNA accumulation in cells [17] most likely
involve processed crRNA stabilization. Cas10 and Csm4 are both
components of the Csm effector complex [14,18,20]; however,
given that Csm3 is essential for complex formation [18] yet dis-
pensable for intermediate crRNA generation [17], the Csm complex
is clearly not strictly required for primary pre-crRNA processing.
Intriguingly, the requirement for Cas10 and Csm4 for post-
processing crRNA stability in cells [17] is not recapitulated in cel-
lular extracts in vitro (Fig. 1C). The roles of Cas10 and Csm4 in
crRNA stabilization therefore remain unclear.
Scanning mutagenesis across an S. epidermidis CRISPR repeat
identified six contiguous nts (G26 through G31; see
Figs. 1A and 6A) that, when changed individually to their respec-
tive Watson–Crick complementary nts, abolished the accumula-
tion of processed crRNAs in vivo [17]. Our use of the purified
rSeCas6 system allowed us to test whether these nts are important
for primary processing itself, as opposed to (for example) post-
processing RNA stability. We found that four of these sites (G26,
G27, G28, and C30) were critical for SeCas6 primary processing.
Mutations at the other two sites (A29 and G31) had limited effects
on rSeCas6 cleavage efficiency, suggesting that their role in Spc1
crRNA accumulation involves post-processing steps, such as stabil-
ity. This is especially plausible because these nts are downstream
of the Repeat 1 cleavage site, i.e. within the ‘‘50 handle” of the pro-
cessed Spc1 crRNA itself.
Some Cas6 substrates form hairpin structures that are impor-
tant for recognition [28–32], whereas others [9,33] do not [11].
When hairpin structures are present, the Cas6 cleavage site is
immediately 30 of the stem. Each repeat within the S. epidermidis
pre-crRNA has the potential to form a four-base-pair G/C-rich stem
with an 8-nt loop immediately upstream of the cleavage site
(Fig. 6A), and limited mutational evidence in vivo supports a role
for stem formation [17]. Our biochemical analyses likewise support
a role for stem formation, especially between the C15/G26 and
C16/G25 pairs (Fig. 6). In vivo, a G28A mutation blocks crRNA accu-
mulation, and that phenotype can be partially reverted by a com-
pensatory C13T mutation, suggesting that the 13–28 base pair
forms and plays a role in processing. We did not observe such an
effect in our in vitro analyses, for reasons that are not clear. Overall,
the picture that emerges from our work, combined with earlier
results [17], is of an RNA–protein interaction that involves the
recognition of a hairpin structure, but in a manner that also
involves base-specific contacts that require specific sequences
(and not just a base-paired configuration) at specific positions,
especially within the G-rich side of the stem. C30 also appears to
be a critical recognition element for SeCas6. Our results are in con-
trast to those with a different, well characterized Type III Cas6
(from P. furiosus), which recognizes single-stranded sequences at
the 50 end of its cognate repeat, based upon both mutational and
crystallographic analyses [9]. A full understanding of SeCas6/pre-
crRNA interaction awaits a similarly high-resolution co-crystal
structure. In the meantime, our work clarifies the requirements
for primary pre-crRNA processing step for the S. epidermidis
RP62a CRISPR-Cas pathway, which has emerged as a prototype
for mechanistic investigation of Type III-A CRISPR interference
[12–14,17,18,20,22,34].
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